$39.11 $1.10 (2.9%)

04:00 PM EDT on 09/20/19

Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY)

CAPS Rating: 5 out of 5

A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.

Current Price $39.11 Mkt Cap $5.9B
Open $39.01 P/E Ratio 0.00
Prev. Close $38.01 Div. (Yield) $129.31 (0.8%)
Daily Range $38.52 - $39.86 Volume 118,147
52-Wk Range $34.70 - $42.78 Avg. Daily Vol. 15

Caps

How do you think NYSE:RDY will perform against the market?

Add Stock to CAPS Watchlist

All Players

434 Outperform
25 Underperform
 

All-Star Players

61 Outperform
6 Underperform
 

Wall Street

5 Outperform
1 Underperform
 

Top NYSE:RDY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

SapphireSeas (76.26)
Submitted December 24, 2009

40% of patents on proprietary drugs will expire by 2014. This stunning figure should be a windfall for Dr. Reddy's, which specializes in generics. Add to this the cheap costs of labor in India, and innovative model practiced by management, and we… More

SCSDogz (< 20)
Submitted September 16, 2008

I see bright things for this company in the future. They have a 4 biologics in the pipeline and 3 acquisitions over the last couple years. But these will not bear fruit for a while. Also RDY is still a young global company that needs to deal with… More

NYSE:RDY VS S&P 500 (SPY)

Fools bullish on NYSE:RDY are also bullish on:

Fools bearish on NYSE:RDY are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about RDY.

Recs

0
Member Avatar jfdihansen (< 20) Submitted: 11/22/2014 1:43:42 PM : Outperform Start Price: $55.73 NYSE:RDY Score: -73.83

Net asset value is less that stock price

Recs

0
Member Avatar racoveanul (71.54) Submitted: 7/3/2014 11:49:50 AM : Outperform Start Price: $42.00 NYSE:RDY Score: -57.48

I picked this stock because it is rated 10 by Stockscouter, it has a dividend and a beta computed by Yahoo Finance of more than 1.

Recs

0
Member Avatar drjohn432 (< 20) Submitted: 9/11/2013 12:35:56 AM : Outperform Start Price: $33.66 NYSE:RDY Score: -60.71

great generic drug maker

Leaderboard

Find the members with the highest scoring picks in RDY.

Score Leader

01123581321

01123581321 (42.94) Score: +312.57

The Score Leader is the player with the highest score across all their picks in RDY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
athome4 57.15 10/10/2008 Outperform 5Y $7.29 +436.68% +252.80% +183.88 0 Comment
yeraz 73.69 10/13/2008 Outperform 5Y $7.77 +403.23% +223.99% +179.24 1 Comment
niwhsa 85.11 11/20/2008 Outperform 3Y $7.02 +456.77% +282.23% +174.54 0 Comment
MedullaOblongata 70.29 11/5/2008 5/4/2010 Outperform 5Y $8.17 +378.98% +208.48% +170.51 0 Comment
XMFHamp 99.89 10/9/2008 Outperform NS $8.29 +372.03% +214.56% +157.47 0 Comment
biotech4ever 22.96 3/20/2009 Outperform 5Y $7.41 +428.06% +285.53% +142.53 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. snazzysnazz 69.74 3/20/2009 Outperform 5Y $7.40 +428.72% +290.37% +138.35 0 Comment
apodeictic 44.62 10/22/2008 Outperform 1Y $8.41 +364.92% +228.23% +136.69 0 Comment
Trimalerus 75.95 3/23/2009 Outperform 5Y $7.54 +418.48% +282.85% +135.63 1 Comment
jenculbertson 72.58 10/16/2008 Outperform 1Y $8.14 +380.61% +245.34% +135.27 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackZacks < 20 10/31/2012 Outperform 3M $32.73 -1.77% -2.00% +0.23 11/12/2012 @ $32.15 1 Comment
TrackZacks < 20 8/9/2012 Outperform 3M $29.90 +6.52% +2.69% +3.83 9/12/2012 @ $31.85 1 Comment
TrackPoisedTo < 20 7/6/2012 Outperform 5Y $28.14 +38.98% +120.23% -81.24 0 Comment
TrackZacks < 20 7/5/2012 Underperform 3M $29.81 +2.58% +0.98% -1.61 7/19/2012 @ $30.58 1 Comment
TrackUltraLong < 20 6/13/2012 Outperform NS $26.52 +47.49% +125.11% -77.63 1 Comment
TrackZacks < 20 2/6/2012 Outperform 3M $33.59 -11.25% +1.74% -12.99 7/5/2012 @ $29.81 1 Comment
TrackZacks < 20 9/1/2011 Underperform 3M $32.92 -9.39% -6.12% +3.27 9/23/2011 @ $29.83 1 Comment
TrackZacks < 20 6/13/2011 Outperform 3M $34.40 +0.05% +3.34% -3.30 7/11/2011 @ $34.42 1 Comment
TrackHSBC 27.26 1/21/2011 Outperform NS $33.98 +15.10% +131.49% -116.39 0 Comment
TrackDeutscheSec 82.12 3/4/2010 Underperform NS $24.09 +75.75% +113.49% +37.74 5/15/2017 @ $42.33 0 Comment
TrackCitigroup 86.51 6/10/2009 Outperform NS $14.23 +174.89% +218.38% -43.48 0 Comment
TrackCreditSuiss 88.08 6/13/2007 Outperform NS $14.04 +178.47% +109.57% +68.90 0 Comment
TrackZacks < 20 5/22/2007 Outperform 3M $16.17 -13.98% -9.87% -4.11 1/31/2008 @ $13.91 1 Comment
TrackJimCramer 86.27 10/12/2006 Underperform 3W $14.05 +178.29% +131.56% -46.73 0 Comment